APOE and Pallister-Hall syndrome: However, in the APOE ε4 non-carrier subgroup, the difference of PHS across clinical classification was not seen (AD: -0.35 [SD: 0.31], MCI: -0.35 [SD: 0.34], CN: -0.37 [SD: 0.36], p = 0.895).